Abstract: A device for relieving back strain for a user who is supporting a substantial weight which is off the user's vertical body axis at his or her front side. The device alleviates the aforementioned difficulties by utilizing the otherwise detrimental forces generated by the off-axis weight to press a rigid plate behind and adjacent to the spine of the device user against the user's spine. This rigid plate is preferably contoured to mirror the shape of the human spine. The device in one embodiment is used as a baby carrier. In another it is used with an abdominal support during pregnancy. In a third embodiment it provides support for the breasts of large breasted women.

Abstract: Reinforced cover for cut-outs in an aerodynamic contour of a vehicle, with a first attachment section 1a attachable to a structural element (2,5) of the vehicle (11); a second elastic section 1c which covers the cut-out (4) which is located between a fixed part 5 and a moving part (6, 12) of the vehicle (11), and provided with a low-friction layer (8) on its inner surface (1e), which comprises a first area (1i) in a rectangular configuration and a second area (1j) with a second cross-section smaller than that of the first area (1i); an outer surface (1k) with a fiberglass layer (7a); a main internal body (9) of a flexible material, a transition section (1g) thickened between the first and the second section, (1a, 1c); flushing the outer surface (1k) of the second section (1c) with the outer surface (5a).

Abstract: A plastic sheet product having a matte finish comprises a core layer of a thermoplastic polymer and at least one layer of a capstock composition which overlies, and is bonded to, at least one face of the core layer. The capstock composition comprises the same or different thermoplastic polymer and contains a plurality of discrete particles immiscible with and dispersed in the thermoplastic polymer of the capstock composition. The sheet product may be prepared by the co-extrusion of the thermoplastic polymer and the capstock composition, and in a particular embodiment, such co-extrusion may be conducted by means of a feedblock. In a particular embodiment, the thermoplastic polymer of the core layer and that of the capstock composition may be the same, such as in the instance of a methylmethacrylate-methylacrylate copolymer.

Abstract: Bicycloheteroaryl compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

Abstract: A web (36) of paper or the like has labels (42) defined therein by printing the web (36) followed by skip cutting (40) the web to define the label boundaries. The skip cutting (40) leaves the labels (42) connected to the remainder of the web (36) by breakable catch points (44). The labels (42) are rendered capable of being applied to product containers (16) by the web (36) having adhesive applied to the side opposite the printing, and the web (36) is rendered capable of being wound up by having an adhesive release coating, such as silicone, applied over the printing.

Abstract: A substantially white powder for use as a filler and/or extender derived from by-products of manufacturing vitreous low alkali, low iron glass fibers, and a method for producing the powder. The filler has very low alkalinity and by virtue of its being essentially free of crystalline silica is non-hazardous to health and therefore safe for consumer-based and industrial-based uses.

Abstract: There is provided novel amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one amino acid ester compound comprising at least one nitric oxide releasing group, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. Also provided are compositions for increasing nitric oxide physiological levels in a subject, methods for increasing nitric oxide physiological levels in a subject, methods for improving a subject's muscle strength, athletic performances and/or lean body mass gain and or performance in a subject.

Abstract: The present invention provides novel nucleic acid and protein sequences for methods and compositions for treating, screening, and diagnosing cardiovascular disease and methods for using these genes and gene products for prevention of cardiac cell death and prevention of cardiac tissue damage resulting from ischemic events in cardiac tissue, as well as other tissue that is subject to damage resulting from an ischemic event. The genes, gene products and agents of the invention are also useful for treating other related clinical or coronary events such as angina, myocardial infarct (MI), and stroke, for monitoring the effectiveness of their treatment, and for drug development. The genes, gene products and agents of the present invention are also provided as pharmaceutical compositions for treatment of cardiovascular disease, ischemic heart disease, myocardial infarct and related conditions. Kits are also provided for the diagnosis, treatment and prognosis of cardiac diseases and related conditions.

Abstract: The invention provides a nucleotide or nucleoside having a base attached to a detectable label via a cleavable linker, characterized in that the cleavable linker contains a moiety selected from the group comprising: Formula (I) (wherein X is selected from the group comprising O, S, NH and NQ wherein Q is a C1-10 substituted or unsubstituted alkyl group, Y is selected from the group comprising O, S, NH and N(allyl). T is hydrogen or a C1-10 substituted or unsubstituted alkyl group and * indicates where the moiety is connected to the remainder of the nucleotide or nucleoside).

Abstract: Methods for isothermal amplification of nucleic acid by the means of a solid support are disclosed. These methods are useful for applications needing high throughput, in particular nucleic acid sequencing.

Abstract: Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.

Abstract: An adherent bioactive calcium phosphate coating is formed on a titanium or titanium alloy substrate by immersing the substrate in an acidic calcium phosphate solution to form a non-apatitic calcium phosphate coating on the substrate. In a second step the coated substrate can be converted to a less reactive coating by being immersed into a basic or neutral solution to convert the coating into an apatite. However if a relatively reactive coating is desired, the second step can be dispensed with.

Abstract: The present invention provides a novel method for treating oral conditions and upper gastrointestinal conditions in a subject by providing an inventive oral dosage form of a pharmaceutical composition comprising an effective amount of at least one antifungal and optionally a flavor modifier and/or salivation component such as an herbal component. In the present invention, the subjects have either not been diagnosed or do not have active or recurrent fungal infections. Specifically, the present invention is directed to chewable dosage forms.

Abstract: The invention provides modified nucleotide or nucleoside molecule comprising a purine or pyrimidine base and a ribose or deoxyribose sugar moiety having a removable 3?-OH blocking group covalently attached thereto, such that the 3? carbon atom has attached a group of the structure —O—Z wherein Z is any of —C(R?)2-O—R?, —C(R?)2-N(R?)2, —C(R?)2-N(H)R?, —C(R?)2-S—R? and —C(R?)2-F, wherein each R? is or is part of a removable protecting group; each R? is independently a hydrogen atom, an alkyl, substituted alkyl, arylalkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocyclic, acyl, cyano, alkoxy, aryloxy, heteroaryloxy or amido group, or a detectable label attached through a linking group; or (R?)2 represents an alkylidene group of formula ?C(R??)2 wherein each R?? may be the same or different and is selected from the group comprising hydrogen and halogen atoms and alkyl groups; and wherein said molecule may be reacted to yield an intermediate in which each R? is exchanged for H or, where Z is —C(R?)2-F, the F is ex